Genetically engineered bacterium for producing malic acid as well as construction method and application of genetically engineered bacterium

A genetically engineered Saccharomyces cerevisiae bacterium with stress resistance elements and enhanced gene expression increases L-malic acid yield and reduces by-products, overcoming industrialization barriers in microbial fermentation.

CN119060868APending Publication Date: 2024-12-03CHANGMAO BIOCHEMICAL ENG CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410687959.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-05-30
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Current methods for producing L-malic acid through microbial fermentation face challenges such as high production costs, genetic instability of domesticated strains, mycotoxins, long fermentation cycles, and low yield at low pH, limiting industrialization.

Method used

A genetically engineered Saccharomyces cerevisiae bacterium expressing stress resistance elements from Pichia guilliermondii and overexpressing pyruvate carboxylase and malate dehydrogenase genes from Rhizopus oryzae and Schizosaccharomyces pombe, with a linker-enhanced fusion protein, to enhance malic acid production without neutralizers.

Benefits of technology

The engineered bacterium achieves a significant increase in L-malic acid yield, reaching up to 28.25 g/L with reduced by-products and no neutralizer use, addressing the limitations of existing methods.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060868A_ABST
    Figure CN119060868A_ABST
Patent Text Reader

Abstract

The invention discloses a genetically engineered bacterium for producing malic acid and a construction method and application thereof, the genetically engineered bacterium takes saccharomyces cerevisiae as host bacteria, and co-expresses stress-resistant element strap genes, ampk genes, gdh genes and tcyc genes derived from pichia guilliermondii; a pyruvate carboxylase gene Ropyc and a malate dehydrogenase gene Romdh which are derived from rhizopus oryzae and a malic acid transporter gene Spmae which is derived from schizosaccharomyces pombe are subjected to overexpression; wherein the Ropyc gene and the Romdh gene are subjected to fusion expression by inserting a linker into the Ropyc gene and the Romdh gene; and the amino acid sequence of the linker is GGGGSGGPGS. The genetically engineered bacterium constructed by the invention can realize efficient production of malic acid under the condition that a neutralizing agent is not added into a fermentation system, and byproducts of heteroacids are less.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of genetic engineering and biotechnology, and in particular to a genetic engineering bacterium producing malic acid and a construction method and application thereof. Background Art

[0002] Malic acid, also known as α-hydroxysuccinic acid or hydroxysuccinic acid, is an important organic acid that is widely found in unripe fruits. Malic acid has two isomers and exists in three forms, namely D-malic acid, L-malic acid and its mixture DL-malic acid, and only L-malic acid with a left-handed structure can be used by organisms. Malic acid plays an important role in human metabolism and can effectively improve athletic ability and resist fatigue. At the same time, L-malic acid has strong decontamination ability and can be added to daily chemical products such as toothpaste and facial cleanser. Therefore, L-malic acid is widely used in food, medicine, health care products and chemical industries, with an annual output of about 40,000 tons, and the potential demand in the world market reaches 60,000 tons per year.

[0003] At present, the production methods of L-malic acid include: microbial fermentation, enzyme conversion, chemical synthesis, etc. The production cost of the chemical synthesis method is low, but the malic acid product produced is DL type, which is not easily absorbed by the human body and has certain toxic side effects. The enzyme conversion method mainly uses fumaric acid as raw material, is simple to operate, and has high yield, but this method requires raw materials of higher purity and needs to be chemically synthesized, which has the disadvantages of large production pollution, expensive raw materials, and high content of impurities in the product. In recent years, the microbial fermentation method has been increasingly valued due to its advantages such as rich raw material sources, low product cost, and low impurity content.

[0004] At present, the main wild strains of microbial fermentation are molds, but there are problems such as mycotoxins in the fermentation products, long fermentation cycles, and uncontrollable mycelium and fungus balls during fermentation. At the same time, a large amount of neutralizers need to be added during mold fermentation, which increases the production cost and the difficulty of separating products downstream. There are also some technologies that use modified brewer's yeast to produce malic acid. For example, a strain of engineered brewer's yeast constructed by Zelled et al. can produce 59.0 g / L malic acid, but an additional 150 g / L of calcium carbonate is required. The current modification of brewer's strains is mainly focused on improving the strain's tolerance to acid and thus reducing the use of neutralizers. The method includes domesticated brewer's yeast strains, but domesticated strains usually have genetic instability problems, which may cause trait loss during passage and preservation. Therefore, increasing the yield of malic acid at low pH is still a difficult problem in current research. These problems have restricted the industrialization process of fermentation to produce L-malic acid. Summary of the invention

[0005] The first purpose of the present invention is to solve the problems of many by-products, large amount of neutralizer used and low malic acid yield at low pH in the existing malic acid production, and to provide a genetically engineered bacterium producing malic acid.

[0006] In order to achieve the above technical objectives, the present invention adopts the following scheme: A genetically engineered bacterium producing malic acid, wherein the genetically engineered bacterium uses Saccharomyces cerevisiae as a host bacterium and expresses a stress resistance element derived from Pichia guilliermondii strap Gene, ampk Gene, gd Gene, tc gene, and overexpressed the pyruvate carboxylase gene from Rhizopus oryzae Ropyc , malate dehydrogenase gene Romdh and a malate transporter gene from Schizosaccharomyces pombe Spmae ; Among them, the Ropyc Gene, Romdh The genes are fused and expressed by inserting a linker; the amino acid sequence of the linker is GGGGSGGPGS.

[0007] As a preferred embodiment, the strap Gene, ampk Gene, gd Gene, tc Gene, Ropyc Gene, Romdh Genes and Spmae The nucleotide sequences of the genes are shown in SEQ ID NOs: 1-7, respectively.

[0008] As a preferred embodiment, the saccharomyces cerevisiae is Saccharomyces cerevisiae RWB837 The second object of the present invention is to provide a method for constructing the above-mentioned genetically engineered bacteria, comprising: using Saccharomyces cerevisiae as a host bacteria, expressing strap Gene, ampk Gene, gd Gene, tc Gene, to obtain a stress-resistant yeast strain; wherein strap Gene, ampk Gene, tc Genes are co-expressed; Using the anti-reverse engineering yeast strain as the host, overexpression Ropyc , Romdh and Spmae Genes, among which Ropyc and Romdh After adding a linker between genes, the fusion protein is expressed.

[0009] As a preferred embodiment, the overexpression Ropyc , Romdh and Spmae Genes include: TEF promoter, TpI promoter, Cyc1t terminator constructed using the host Saccharomyces cerevisiae strain Ropyc , Romdh The expression cassette was constructed using the Gap promoter and Pgk1t terminator from the host Saccharomyces cerevisiae strain. Spmae The expression cassette Ropyc , Romdh The expression cassette and Spmae The expression cassettes were connected to the vectors and introduced into the anti-retroviral engineering yeast strain.

[0010] The third object of the present invention is to provide the use of the above genetically engineered bacteria in the fermentation production of malic acid.

[0011] As a preferred embodiment, the genetically engineered bacteria produces malic acid by fermentation in a fermentation system without a neutralizer. The fermentation system without a neutralizer means that the fermentation medium of the shake flask culture does not contain a neutralizer, and the neutralizer is not introduced to adjust the pH in the fermentation tank culture.

[0012] As a preferred embodiment, the genetically engineered bacteria are subjected to seed culture in a seed culture set; the seed culture medium components are: YNB 6.7 g / L, glucose 20 g / L, Fe(NH4)2(SO4)2 0.01 μmol / L, amino acid solution; Amino acid solution: adenine 0.002 g / L, valine 0.015 g / L, isoleucine 0.003 g / L, arginine 0.002 g / L, histidine 0.002 g / L, leucine 0.01 g / L, lysine 0.003 g / L, methionine 0.002 g / L, phenylalanine 0.005 g / L, threonine 0.002 g / L, tryptophan 0.002 g / L, tyrosine 0.003 g / L, aspartic acid 0.001 g / L, serine 0.004 g / L, glutamic acid 0.001 g / L.

[0013] As a preferred embodiment, the fermentation medium of the genetically engineered bacteria comprises 90-100 g / L glucose, 3 g / L KH2PO4, 6.6 g / L K2SO4, 0.5 g / L MgSO4·7H2O, 1 g / L urea, 1 ml / L vitamin solution, and 1 ml / L trace elements; Vitamin solution: biotin 0.05 mg / L, calcium pantothenate 1 mg / L, niacin 1 mg / L, inositol 25 mg / L, thiamine hydrochloride 1 mg / L, pyridoxine 1 mg / L, p-aminobenzoic acid 0.2 mg / L.

[0014] Trace elements: EDTA 15 mg / L, ZnSO4·7H2O 4.5 mg / L, CoCl2·6H2O 0.3 mg / L, MnCl2·4H2O 1 mg / L, CuSO4·5H2O 0.3 mg / L, CaCl2·2H2O 4.5 mg / L, FeSO4·7H2O 3 mg / L, NaMoO4·2H2O 0.4 mg / L, H3BO4 1 mg / L, KI 0.1 mg / L.

[0015] Furthermore, 0.05-0.15 mg / L biotin is exogenously added to the fermentation medium.

[0016] As a preferred embodiment, the fermentation temperature of the genetically engineered bacteria is 30-33°C The present invention obtains a stress-resistant and acid-resistant chassis cell by introducing stress-resistant genes into Saccharomyces cerevisiae, and expresses pyruvate decarboxylase and malate dehydrogenase from different sources in combination. Ropyc and Romdh and the source of Schizosaccharomyces pombe Spmae The recombinant strain T001 obtained by using the gene has the strongest malic acid production ability. At the end of 96 h of fermentation, the malic acid production reached 10.25 g / L, the malic acid yield was 12.80 g / g, the production intensity was 0.108 g / L / h, and the pyruvic acid accumulation was only 5.01 g / L. Ropyc and Romdh Linker-GGGGSGGGGS or Linker-GGGGSGGPGS was added between genes to express the fusion protein. The L-malic acid yield of Linker-GGGGSGGPGS reached 20.75 g / L. Subsequently, the fermentation conditions were optimized by strain enrichment and response surface analysis, and the L-malic acid yield in the shake flask reached 28.25 g / L, which was 175.61% higher than that before optimization.

[0017] The genetically engineered bacteria constructed by the present invention can achieve efficient production of malic acid without adding a neutralizer to the fermentation system, and with few by-products. In addition, the present invention is the first to introduce a linker into the malic acid-producing Saccharomyces cerevisiae to express key genes in series, effectively reducing the steric hindrance between the substrate and the product without affecting the protein conformation and function, achieving the enhancement of protein function, and further increasing the yield of malic acid at low pH (without adding a neutralizer), providing a new idea for increasing the yield of L-malic acid by biological methods. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] The present invention will be further described in detail below in conjunction with the accompanying drawings and specific embodiments, and the above and / or other advantages of the present invention will become more clear.

[0019] Figure 1 Construction and verification of stress-resistant element recombinant plasmid (a) ampk Gene (b) strap Gene (c) tc Gene (d) gd Gene.

[0020] Figure 2 Growth verification of original Saccharomyces cerevisiae and engineered stress-tolerant Saccharomyces cerevisiae.

[0021] Figure 3 TEF- Ropyc -Eno2t (4433 bp), TpI- Romdh -Cyc1t (1832 bp) and Gap- Spmae - Pgk1t (2356 bp) three expression cassette fragments.

[0022] Figure 4 DH5α / pRS426 / TEF- Ropyc / TpI- Romdh / Gap- Spmae Colony PCR verification.

[0023] Figure 5 Positive transformants Ropyc , AfD and Spmae Colony PCR identification (colony No. 1 was identified as lanes 1, 2, and 3; colony No. 2 was identified as lanes 4, 5, and 6; colony No. 3 was identified as lanes 7, 8, and 9).

[0024] Figure 6 The changes in glucose consumption and organic acid production of the recombinant strain T001 within 96 hours.

[0025] Figure 7 The changes in glucose consumption and organic acid production of the recombinant strain T002 within 96 hours.

[0026] Figure 8 The changes in glucose consumption and organic acid production of the recombinant strain T003 within 96 hours.

[0027] Fig. 9 The changes in glucose consumption and organic acid production of the recombinant strain T004 within 96 hours.

[0028] Fig.10 The changes in glucose consumption and organic acid production of the recombinant strain L001 within 96 hours.

[0029] Fig.11 The changes in glucose consumption and organic acid production of the recombinant strain L002 within 96 hours.

[0030] Fig.12 The effect of fermentation temperature on L-malic acid production.

[0031] Fig.13 This is the effect of biotin addition on L-malic acid production.

[0032] Fig.14 This is the effect of initial glucose on L-malic acid production.

[0033] Fig.15 Interactive effects of fermentation temperature and biotin addition on L-malic acid production.

[0034] Fig.16 Interactive effects of fermentation temperature and initial glucose concentration on L-malic acid production.

[0035] Fig.17 Interactive effects of initial glucose concentration and biotin addition on L-malic acid production. DETAILED DESCRIPTION

[0036] The starting strain (host bacteria) used in the examples is Saccharomyces cerevisiae The RWB837 strain was donated by Antonius JA van Maris of Delft University in the Netherlands. The specific information of the strain has been disclosed in detail in a related paper titled Directed Evolution of Pyruvate Decarboxylase-Negative Saccharomyces cerevisiae, Yielding a C2-Independent, Glucose-Tolerant, and Pyruvate-Hyperproducing Yeast.

[0037] Example used Meyerozyma guilliermondiiEA20 has been disclosed in the applicant's prior application CN114574374A (accession number: CCTCC NO: M 2022053), the stress-resistant element ampk , tc , strap and gd All were derived from strain EA20.

[0038] The vector plasmid 113-GPD-TEF- hph It has been disclosed in the applicant's prior article Jing Y, Wang J, Gao H, Jiang Y, Jiang W, Jiang M, Xin F, Zhang W. Enhanced β-caroteneproduction in Yarrowia lipolytica through the metabolic and fermentation engineering. J Ind Microbiol Biotechnol. 2023 Feb 17;50(1):kuad009. doi:10.1093 / jimb / kuad009. PMID: 37055369; PMCID: PMC10124129.

[0039] The culture medium formula in the embodiment is as follows: LB medium: peptone 10 g / L, yeast powder 5 g / L, sodium chloride 10 g / L.

[0040] S.C. -Ura medium: YNB (amino-free yeast nitrogen source) 6.7 g / L, glucose 20 g / L, Fe(NH4)2(SO4)2 0.01 μmol / L, sterilized by high-pressure steam at 121℃ for 15 min; the amino acid solution was filtered and sterilized and added when pouring the culture medium.

[0041] Amino acid solution: Amino acid solution: Adenine 0.002 g / L, Valine 0.015 g / L, Isoleucine 0.003 g / L, Arginine 0.002 g / L, Histidine 0.002 g / L, Leucine 0.01 g / L, Lysine 0.003 g / L, Methionine 0.002 g / L, Phenylalanine 0.005 g / L, Threonine 0.002 g / L, Tryptophan 0.002 g / L, Tyrosine 0.003 g / L, Aspartic acid 0.001 g / L, Serine 0.004 g / L, Glutamic acid 0.001 g / L.

[0042] S.C. -Ura solid medium: S.C. -Ura medium was supplemented with 20 g / L agar powder.

[0043] Stress resistance fermentation verification medium: YNB (amino-free yeast nitrogen source) 6.7 g / L, glucose 20 g / L, Fe(NH4)2(SO4)20.01 μmol / L, 121℃ high pressure steam sterilization for 15 min; amino acid solution is filtered and sterilized and added when pouring the culture medium, and malic acid is added exogenously at 0-30 g / L.

[0044] Ampicillin resistance plate: 100 mg / L ampicillin sodium, agar powder, and the rest is the same as LB medium.

[0045] Hygromycin resistance plate: 200 mg / L hygromycin; agar powder 20 g / L, the rest S.C. -Ura solid medium.

[0046] YPD medium: yeast powder 10 g / L, peptone 20 g / L, glucose 20 g / L.

[0047] Fermentation medium: glucose 100 g / L, KH2PO4 3 g / L, K2SO4 6.6 g / L, MgSO4·7H20 0.5 g / L, sterilized by high-pressure steam at 110℃ for 20 min, urea 1 g / L (filter sterilized), vitamin solution 1 ml / L (filter sterilized), trace elements 1 ml / L (high-temperature sterilized at 121℃) and added after the culture medium has cooled.

[0048] The vitamin solution includes: biotin 0.05 mg / L, calcium pantothenate 1 mg / L, niacin 1 mg / L, inositol 25 mg / L, thiamine hydrochloride 1 mg / L, pyridoxine 1 mg / L, and p-aminobenzoic acid 0.2 mg / L.

[0049] Trace elements: EDTA 15 mg / L, ZnSO4·7H2O 4.5 mg / L, CoCl2·6H2O 0.3 mg / L, MnCl2·4H2O 1 mg / L, CuSO4·5H2O 0.3 mg / L, CaCl2·2H2O 4.5 mg / L, FeSO4·7H2O 3 mg / L, NaMoO4·2H2O 0.4 mg / L, H3BO4 1 mg / L, KI 0.1 mg / L.

[0050] Seed enriched culture medium: peptone 20 g / L, yeast powder 10 g / L, glucose 20 g / L, K2HPO4 2.23 g / L, KH2PO4 11.8 g / L, YNB 6.7 g / L, sterilized by high pressure steam at 110℃ for 20 min, biotin 0.05 mg / L, urea 2.3 g / L, filtered and sterilized, added to the culture medium.

[0051] Example 1 Construction, identification and fermentation verification of stress resistance chassis: Construction and characterization of stress-tolerant yeast chassis: YPD culture Meyerozyma guilliermondii EA20 (laboratory preservation, strong stress resistance) genome extraction, using four pairs of primers strap F / R, ampk F / R, gd F / R, tc F / R amplified four stress-resistant elements with pTEF promoter and tCYC1 terminator homology arms at both ends. strap (2504bp), ampk (1068bp), gd (4170bp), tc (1397 bp), plasmid 113-GPD-TEF- hph Linearize with restriction endonuclease swa1; connect and integrate the linearized vector plasmid and the target gene with corresponding promoter and terminator homology arms at both ends through a one-step cloning transformation kit to obtain a new plasmid, transform it into E. coli competent DH5α, and spread it on the ampicillin-resistant LB screening plate. The colony PCR results are as follows: Figure 1 The target gene fragment size and sequencing results were correct, and four plasmids 113-GPD-TEF- hph - ampk 、113-GPD-TEF- hph - strap 、113-GPD-TEF- hph - tc and 113-GPD- TEF - hph - gd Next, using primers ampk F / R in 113-GPD-TEF- hph - ampk PCR amplification to obtain the target fragment ampk , the target fragment was cloned using restriction endonucleases Pme I and Sma I ampk and plasmid 113-GPD-TEF- hph - tcThe enzyme was linearized and connected and integrated by one-step cloning transformation kit to obtain a new recombinant plasmid 113-GPD-TEF- hph - tc - ampk , transferred into competent E. coli DH5α, and plated on LB screening plates with ampicillin resistance (100 mg / L). Positive clones were selected for PCR verification and sent to the company for further sequencing verification. Then the above operation was repeated to obtain the co-expression plasmid 113-GPD-TEF- hph - tc - ampk - strap For specific primers, please refer to the applicant's prior application CN116836826A.

[0052] Finally, the co-expression plasmid 113-GPD-TEF- hph - tc - ampk - strap and recombinant plasmid 113-GPD-TEF- hph - gd The restriction endonuclease Not I was used for linearization and then introduced into Saccharomyces cerevisiae by electroporation. Saccharomyces cerevisiae RWB837 competent cells were plated on hygromycin selection medium. After culturing for 2-3 days, positive transformants were selected for colony PCR identification. The results of colony PCR verification were as follows: Figure 1 . strap , ampk , gd , tc The band sizes on gel electrophoresis were 2504bp, 1068bp, 4170bp, and 1397bp, respectively, which were consistent with the gene band sizes. The DNA sequence detection results were verified and compared to confirm that there was no base mutation. The stress-resistant element was successfully introduced into Saccharomyces cerevisiae, and the stress-resistant engineered yeast strain Saccharomyces cerevisiae M build successful.

[0053] Fermentation verification of stress-resistant yeast chassis: After activating the original strain and the engineered strain in YPD medium until they grow to the logarithmic growth phase, they are inoculated into stress-resistant fermentation verification medium to make the initial OD 600 The OD value was 0.1, cultured for 72 h, and measured every 24 h. 600 .

[0054] like Figure 2 It can be seen that at pH = 7, there was no significant difference in the growth of the original strain and the engineered strain; however, when 30 g / L malic acid was added exogenously to reduce the concentration of the fermentation broth to pH = 3, the growth of the original strain was significantly inhibited, while the engineered strain was still able to maintain good growth, indicating its strong stress resistance. strap Regulates cell membrane phospholipid and glycerol composition, endocytosis, and enhances the integrity of the cell membrane of Saccharomyces cerevisiae; Gene ampk Accelerate the glycolysis pathway, promote the synthesis of ATP and increase cell metabolic activity; Gene gd Increase the glutathione content in the strain, convert glutamate into the TCA cycle intermediate α-ketoglutarate (α-KG) to replenish the accelerated regulation of the tricarboxylic acid cycle and improve the metabolic activity of the strain; and the gene tc Regulate membrane protein function and energy regulation in cell membrane, and regulate membrane permeability. The introduction of these four genes effectively enhances the stress resistance of Saccharomyces cerevisiae and its resistance to acidic environment.

[0055] Biomass OD 600 Measurement method: dilute the sample to an appropriate multiple, use pure water as a control, and measure its absorbance at a wavelength of 600nm. 600 =Absorbance*dilution factor.

[0056] Example 2 Recombinant strain T001 (M+pRS426 / TEF- Ropyc / TpI- Romdh / Gap- Spmae ) construction, identification and fermentation validation: Construction and identification of recombinant strain T001: DNA was extracted from Rhizopus oryzae cultured with PDA Romdh , Ropyc The target gene fragment, after the sequencing result is correct, the product is purified and recovered using a gel purification kit and stored in a -20℃ low-temperature refrigerator for future use; Spmae Gene manipulation is the same as above. Ropyc Gene, Romdh Genes and Spmae The nucleotide sequences of the genes are shown in SEQ ID NOs: 5-7, respectively.

[0057] Obtained from host bacteria (Saccharomyces cerevisiae Saccharomyces cerevisiae The promoters TEF1p (426 bp), TpI1p (510 bp) and Gap (697 bp), and terminators Eno2t (400 bp), Cyc1t (248 bp) and Pgk1t (283 bp) of the genome of RWB837 were cloned and connected using the primer design software Primer Premier. Then, three expression cassette fragments, namely TEF- Ropyc -Eno2t (4433 bp), TpI- Romdh-Cyc1t (1832 bp) and Gap- Spmae -Pgk1t (2356 bp) ( Figure 3 Plasmid pRS426 was linearized by single restriction digestion with Sac I, and three expression cassettes TEF- Ropyc -Eno2t (4433 bp), TpI- Romdh -Cyc1t (1832 bp) and Gap- Spmae -Pgk1t (2356 bp) was connected to the pRS426 vector. After chemical transformation, it was introduced into the DH5α competent cell. The results of colony PCR identification were as follows Figure 4 The sizes and sequencing results of the three expression cassette fragments were correct. Then the plasmid was digested with Sac I and introduced into Saccharomyces cerevisiae by electroporation. Saccharomyces cerevisiae M competent cells, spread on S. c-Ura After 2-3 days of culture on solid medium, positive transformants were selected for colony PCR identification. The results of colony PCR verification were as follows: Figure 5 The band size was correct, the sequencing was correct and there was no mutation, and the recombinant strain T001 was successfully constructed.

[0058] Fermentation of recombinant strain T001: The recombinant strain T001 was inoculated into a seed-rich medium and cultured at 30°C and 200 r / min for 48 h. Then, it was transferred to a fermentation medium at 30°C and 200 r / min for fermentation verification. The fermentation broth was taken every 24 h, and the final sample was taken at 96 h of fermentation. The fermentation broth was centrifuged and the supernatant was taken to determine the glucose and organic acid contents ( Figure 6 ).

[0059] Determination of glucose content: Take 2 mL of sample, centrifuge at 12000 r / min for 60 s, take 1 mL of supernatant and dilute 100 times, use SBA-40C biosensor to determine the glucose content in the fermentation broth, sugar content (g / L) = reading value * 100.

[0060] Determination of organic acids: High performance liquid chromatography (HPLC) was used. The fermentation broth was centrifuged at 1200 r / min for 120 s, and the supernatant was taken. The supernatant was diluted to an appropriate multiple and filtered with a 0.22 μm water filter membrane. The sample was placed in a liquid sample bottle and then placed in a liquid chromatography instrument for detection. The instrument model was the American Dionex Ultimate 3000 series; the sugar column model used was BIO-RAD, Aminx, HPX-87H, USA; the main component of the mobile phase was 0.2 g / L sulfuric acid, the column temperature was controlled at 55°C, the detection wavelength of the UV detector was 215 nm, the flow rate was 0.5 mL / min, and the injection volume was 10 μL.

[0061] Depend on Figure 6 It can be seen that during the fermentation, glucose was almost consumed at 72 h, and pyruvate reached a maximum concentration of 26 g / L at 24 h, and then the concentration continued to decrease. After 24 h, the recombinant strain T001 converted the accumulated pyruvate into Ropyc + Romdh + Spmae The combined metabolic pathway was converted into malic acid. At the end of 96 h fermentation, the malic acid concentration reached a maximum of 10.25 g / L, the malic acid yield was 12.80 g / g, the production intensity was 0.108 g / L / h, and the residual pyruvic acid concentration was 5.01 g / L.

[0062] Example 3 Recombinant strain T002 (M+pRS426 / TEF- Ropyc / TpI- AfD / Gap- Spmae ) construction, identification and fermentation validation.

[0063] Obtaining the target gene from Aspergillus flavus Ropyc (3540 bp) and AfD (996 bp), construct TEF-Afpyc-Eno2t, TpI- AfD -Eno2t and Gap- Spmae -Pgk1t three expression cassettes were introduced into M competent cells, and the specific molecular operations were the same as in Example 2. The recombinant strain T002 was successfully constructed as verified by colony PCR and sequencing results. The fermentation of the recombinant strain T002 was carried out in the same manner as in Example 2. The changes in glucose consumption and organic acid production were shown in Figure 7 .

[0064] Depend on Figure 7 It can be seen that during the fermentation, glucose was consumed at 72 h, pyruvate reached a maximum concentration of 25 g / L at 24 h to 48 h, and the malic acid concentration remained unchanged during the fermentation. After 96 h, the increase in malic acid concentration was accompanied by a decrease in pyruvic acid. At the end of the 96 h fermentation, the malic acid concentration reached a maximum of 6.54 g / L, and the residual pyruvic acid concentration was 4.2 g / L. The mass yield of malic acid synthesis was 8.14 g / g, and the production intensity was 0.068 g / L / h. Compared with the recombinant strain T001, the concentration of malic acid decreased by 3.71 g / L.

[0065] Example 4 Recombinant strain T003 (M+pRS426 / TEF- Afpyc / TpI- AfD / Gap- Spmae ) construction, identification and fermentation validation.

[0066] Building TEF- Afpyc -Eno2t, Gap- Spmae -Pgk1t and TpI- AfD -Eno2t three expression cassettes were introduced into M competent cells, and the specific molecular operations were the same as in Example 2. The recombinant strain T003 was successfully constructed as verified by colony PCR and sequencing results. The fermentation of the recombinant strain T003 was carried out in the same manner as in Example 2. The changes in glucose consumption and organic acid production were shown in Figure 8 .

[0067] During the fermentation, glucose was consumed at 96 h, and pyruvate reached a maximum concentration of 28.3 g / L at 48 h. During the fermentation, the concentration of malic acid showed a continuous upward trend. At the end of the 96 h fermentation, the malic acid concentration reached a maximum of 9.55 g / L, and the residual concentration of pyruvic acid was 3.1 g / L. The mass yield of malic acid synthesis was 11.72 g / g, and the production intensity was 0.10 g / L / h. Compared with the recombinant strain T001, the concentration of malic acid decreased by 0.7 g / L, but the malic acid accumulated by the recombinant strain T002 increased by 3.01 g / L.

[0068] Example 5 Recombinant strain T004 (M+pRS426 / TEF- Afpyc / TpI- Romdh / Gap- Spmae ) construction, identification and fermentation validation.

[0069] Building TEF- Afpyc -Eno2t、TpI- Romdh -Eno2t and Gap- Spmae -Pgk1t and three expression cassettes were introduced into M competent cells, and the molecular specific operations were the same as in Example 2. The recombinant strain T004 was successfully constructed as verified by colony PCR and sequencing results. The fermentation of the recombinant strain T004 was carried out in the same manner as in Example 2. The changes in glucose consumption and organic acid production were shown in Fig. 9 .

[0070] like Fig. 9 As shown in Figure 2, pyruvate reached a maximum concentration of 27.5 g / L at 24 h, and then the concentration continued to decrease. After 24 h, the recombinant strain T004 converted the accumulated pyruvate into Afpyc + Romdh + Spmae The combined pathway was converted into malic acid. At the end of 96 h of fermentation, the malic acid concentration reached a maximum of 8.28 g / L, and the residual pyruvic acid concentration was 3.4 g / L. The mass yield of malic acid synthesis was 10.27 g / g, and the production intensity was 0.0886 g / L / h.

[0071] Example 6 Construction, identification and fermentation verification of recombinant strain L001 (Linker GGGGSGGGGS) and recombinant strain L002 (Linker GGGGSGGPGS). Construction of recombinant strain L001 ( Ropyc- GGGGSGGGGS- Romdh ). Use the primer design software Primer Premier to design the connection fragment: F 426 : GAGCTCCACCGCGGTGGCG R 426 : CAGCTTTTGTTCCCTTTAGTGAGGG F TEF : GCCACCGCGGTGGAGCTCCCACACACCATAGCTTCAA R TET :TCATTAGAAAGAAAGCATAGCAATCTAATCTAAG F Ropyc :TCATTAGAAAGAAAGCATAGCAATCTAATCTAAG R Ropyc : TAAAGGGAACAAAAGCTGTCAGGCTTCCTCCTTTAC Then, a plasmid, pRS426-TEF- Ropy , and then introduced into DH5α competent cells through chemical transformation. Similarly, design primers: F 426 , R 426 : (Same as above) F TPI : GCCACCGCGGTGGAGCTCCCTACGTTAGTGTGAGCGGGA R TPI :TTTTAGTTTATGTATGTGTTTTTTGTAGTTATAGATTTAAG F Romdh :AAAACACATACATAAACTAAAAATGTTTGCCGCCTCTCGTG R Romdh : TGACATAACTAATTACATGATTATTGAACAAAGCTGTTACCCTTG F cyc1t: TCATGTAATTAGTTATGTCACGCTTACA R cyc1t :ACTAAAGGGAACAAAAGCTGGCAAATTAAAGCCTTCGAGCG Then, a plasmid, pRS426-TPI- Romdh -CYC1t, and then introduced into DH5α competent cells through chemical transformation. 426 , R 426 To extend the target fragment on the pRS426 plasmid, the aforementioned F TEF , F1: CCCGCTCACACTAACGTAGGGCTGCCGCCGCCGCCGCTGCCGCCGCCGCCTCAGGCTTCCTCCTTTACAACC extended pRS426-TEF- Ropy The target fragment on the above, F2: CCTACGTTAGTGTGAGCGGGATTTA, the aforementioned R Cyc1t Expand pRS426-TPI- Romdh -CYC1t target fragment, and then through a one-step cloning reaction to obtain the final plasmid, namely pRS426-TEF- Ropyc -GGGGSGGGGS-TPI- Romdh -Cyc1t was introduced into DH5α competent cells through chemical transformation. The colony was verified to be correct, and then the plasmid was double-digested with HindIII and MfeI to obtain the digestion product.

[0072] Similarly, design primers: F 426 , R 426 : (Same as above) F GAP : CCGCCACCGCGGTGGAGCTCGACTTTTTTTTTTCAGCCGATCGCTTATCT R GAP :TTCTTCTCGTACGAAGAAGTATTACTCATTTTTTAT F Spmae : ATACTTCTTCGTACGAGAAGAAATGGGTGAACTTAAGGAAATCCTTAAACAACGCTAT R Spmae :ATTCTTAGTTAAAAGCACTTCAAACTGATTCATGCTCGCTGGA F Eno2t: AGTGCTTTTAACTAAGAATTATTAGTCTTTTCTGC R Eno2t : ACTAAAGGGAACAAAAGCTGAGGTATCATCTCCATCTCCCATATGCATA Then, a plasmid, pRS426-GAP- Spmae -Eno2t was introduced into DH5α competent cells through chemical transformation, and the colony verification was successful. Then, the plasmid was double-digested with BamHⅠ and AhdⅠ to obtain the digestion product.

[0073] Finally, the double digestion products of BamHⅠ and AhdⅠ and HindIII and MfeI were introduced into Saccharomyces cerevisiae by electroporation. Saccharomyces cerevisiae M competent cells, spread on S. c-Ura After 2-3 days of culture on solid medium, positive transformants were selected for colony PCR identification. The results of colony PCR verification were as follows: Figure 5 The band size was correct, and the sequencing was correct without mutation. The recombinant strain L001 was successfully constructed.

[0074] Recombinant strain L002 ( Ropyc- GGGGSGGPGS - Romdh The molecular operations were the same as above, and the recombinant strain L002 was successfully constructed as verified by colony PCR and sequencing results.

[0075] The fermentation of recombinant strains L001 and L002 was carried out in the same manner as in Example 2. The changes in glucose consumption and organic acid production were as follows: Figure 10-11 . After 96h of fermentation, the recombinant strain L001 produced 15.35g / L of malic acid, while the recombinant strain L002 had a higher malic acid concentration of 20.75g / L and a residual pyruvic acid of 2.5 g / L, which were lower than those of the recombinant strains T001-004. Fusion protein refers to the synergistic integration of two or more protein molecules to form a complex, which has the effect of enhancing the efficiency of electron transfer, reducing the steric hindrance between substrates and products, or achieving cofactor regeneration. Linker GGGGSGGPGS has a better effect than Linker GGGGSGGGGS. The reason is that LinkerGGGGSGGPGS contains proline, and the proline side chain is a unique ring structure, which gives it a special conformational rigidity. On the basis of reducing the steric hindrance between proteins, it will not affect the normal conformation and function between the two proteins, thereby achieving the enhancement of protein function and increasing the yield of malic acid.

[0076] Example 7 The fermentation conditions of the recombinant strain L002 with the introduced Linker GGGGSGGPGS were optimized.

[0077] Optimization of liquid culture medium for fermentation seeds. The experiment found that during the seed cultivation period, the bacteria S. C-Ura The growth rate in the medium is slower than that in the seed-rich medium. However, during the fermentation stage, the bacteria S. C-Ura The yield of malic acid enriched in the medium is higher than that of the cells enriched in the seed-rich medium. Because the cells are enriched in the seed medium, the nutrients in the medium are high and do not have the screening ability. When the cells grow in the rich medium, it is easy to lose the experimentally constructed plasmid pRS426 / TEF- Ropyc- linker - Romdh / Gap- Spmae , resulting in poor subsequent fermentation results. S. C-Ura The culture medium is used as a seed culture medium to screen and enrich the recombinant strains with the constructed plasmid, which enhances the subsequent fermentation effect. S. C-Ura Compared with commercially available culture media, the culture medium has relatively simplified components and reduced the concentration of the amino acid solution.

[0078] Optimization of fermentation medium. First, single-factor studies were conducted on the three fermentation conditions of fermentation temperature (28°C, 30°C, 33°C, 35°C), exogenous biotin addition (0.025, 0.05, 0.1, 0.15, 0.2 mg / L), and initial glucose concentration (60, 80, 100, 120 g / L), and then the response surface method was used to optimize the fermentation factors. Through 13 experiments with different single-factor combinations given by the response surface software, a three-factor surface was successfully obtained. Through surface model analysis, the optimal fermentation conditions for the recombinant strain T001 to produce L-malic acid were fermentation temperature of 32.58°C, exogenous biotin addition (excluding biotin in the vitamin solution) of 0.09 mg / L, and initial glucose concentration of 90.32 g / L. Under the optimal fermentation conditions, the predicted value of L-malic acid production was 27.05 g / L. The optimal fermentation was verified, and the fermentation process was as follows: the recombinant strain L002 was inoculated in S. C-Ura The culture medium was cultured at 30℃ and 200 r / min for 48 h, and then transferred to the fermentation medium (glucose concentration 90.32 g / L, exogenously added 0.09 mg / L biotin) and fermented in a shake flask at 32.58℃ and 200 r / min. The fermentation broth was taken every 24 h, and the final sample was taken at 96 h of fermentation. The fermentation broth was centrifuged and the supernatant was taken to determine the organic acid content. The results showed that the average L-malic acid yield was 28.25 g / L, which was 36.14% higher than the fermentation yield without single factor optimization.

[0079] The above embodiments are only used to analyze and understand the preparation method and application scope of the present invention, but the present invention is not limited to the above embodiments. If ordinary technicians in the field are inspired by them, they can directly change, replace, modify, etc. the present invention, which should all fall within the scope of protection of this patent.

Claims

1. A genetically engineered bacterium producing malic acid, characterized in that: The genetically engineered bacteria uses Saccharomyces cerevisiae as a host bacteria and expresses a stress resistance element derived from Pichia guilliermondii. strap Gene, ampk Gene, gd Gene, tc gene, and overexpressed the pyruvate carboxylase gene from Rhizopus oryzae Ropyc , malate dehydrogenase gene Romdh and a malate transporter gene from Schizosaccharomyces pombe Spmae ; Among them, the Ropyc Gene, Romdh The genes are fused and expressed by inserting a linker; the amino acid sequence of the linker is GGGGSGGPGS.

2. The genetically engineered bacterium according to claim 1, characterized in that Said strap Gene, ampk Gene, gd Gene, tc Gene, Ropyc Gene, Romdh Genes and Spmae The nucleotide sequences of the genes are shown in SEQ ID NOs: 1-7, respectively.

3. The genetically engineered bacterium according to claim 1, characterized in that: The saccharomyces cerevisiae is Saccharomyces cerevisiae RWB837.

4. The method for constructing the genetically engineered bacteria according to any one of claims 1 to 3, characterized in that: Using Saccharomyces cerevisiae as the host strain, the expression strap Gene, ampk Gene, gd Gene, tc Gene, to obtain a stress-resistant yeast strain; wherein strap Gene, ampk Gene, tc Genes are co-expressed; Using the anti-reverse engineering yeast strain as the host, overexpression Ropyc , Romdh and Spmae Genes, among which Ropyc and Romdh After adding a linker between genes, the fusion protein is expressed.

5. Use of the genetically engineered bacteria according to any one of claims 1 to 3 in fermentation production of malic acid.

6. The use according to claim 5, characterized in that: The genetically engineered bacteria produces malic acid by fermentation in a fermentation system without a neutralizer.

7. The use according to claim 5, characterized in that The genetically engineered bacteria are cultured in a seed culture set; the seed culture medium comprises: YNB 6.7 g / L, glucose 20 g / L, Fe(NH4)2(SO4)2 0.01 μmol / L, and amino acid solution; Amino acid solution: adenine 0.002 g / L, valine 0.015 g / L, isoleucine 0.003 g / L, arginine 0.002 g / L, histidine 0.002 g / L, leucine 0.01 g / L, lysine 0.003 g / L, methionine 0.002 g / L, phenylalanine 0.005 g / L, threonine 0.002 g / L, tryptophan 0.002 g / L, tyrosine 0.003 g / L, aspartic acid 0.001 g / L, serine 0.004 g / L, glutamic acid 0.001 g / L.

8. The use according to claim 5, characterized in that The fermentation medium of genetically engineered bacteria contains 90-100 g / L glucose, 3 g / L KH2PO4, 6.6 g / L K2SO4, 0.5 g / L MgSO4·7H2O, 1 g / L urea, 1 ml / L vitamin solution, and 1 ml / L trace elements. Vitamin solution: biotin 0.05 mg / L, calcium pantothenate 1 mg / L, niacin 1 mg / L, inositol 25 mg / L, thiamine hydrochloride 1 mg / L, pyridoxine 1 mg / L, p-aminobenzoic acid 0.2 mg / L; Trace elements: EDTA 15 mg / L, ZnSO4·7H2O 4.5 mg / L, CoCl2·6H2O 0.3 mg / L, MnCl2·4H2O1 mg / L, CuSO4·5H2O 0.3 mg / L, CaCl2·2H2O 4.5 mg / L, FeSO4·7H2O 3 mg / L, NaMoO4·2H2O0.4 mg / L, H3BO4 1 mg / L, KI 0.1 mg / L.

9. The use according to claim 8, characterized in that: 0.05-0.15 mg / L biotin is exogenously added to the fermentation medium.

10. The use according to claim 5, characterized in that: The fermentation culture temperature of genetically engineered bacteria is 30-33°C.

Citation Information

Patent Citations

  • Bacterial strain for producing 2-phenethyl alcohol and application thereof

    CN114574374A

  • Genetically engineered bacterium for efficiently synthesizing 2-phenethyl alcohol as well as construction method and application of genetically engineered bacterium

    CN116836826A